Exos Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,100	Closed	-$250K	–	368
2021 Q3	$250K	Hold	25,100	–	–	0.13%	185
2021 Q2	$260K	Buy	25,100 +20,100	+402%	+$208K	0.14%	232
2021 Q1	$51K	Hold	5,000	–	–	0.04%	295
2020 Q4	$57K	Buy	+5,000	New	+$57K	0.09%	160